In this session from Thryve’s Before It Hurts series, we explore why healthcare systems still struggle to reward prevention, and what it would take to finally make upstream care both viable and scalable.
Why prevention rarely pays in current funding models—and what insurers need instead.
How reactive care inflates costs and reduces outcomes, especially for chronic conditions.
How wearable-derived metrics like VO₂max and METmax can signal risk before it becomes cost.
What needs to change in Morbi-RSA and beyond to support proactive care strategies.
What a modern, prevention-friendly reimbursement structure could look like.
Bring your questions for an open discussion with Paul and Mathias.
